Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 32, 2015, Pages E4354-E4363

  Inci, Fatih ^a   Filippini, Chiara ^b   Baday, Murat ^a   Ozen, Mehmet Ozgun ^a   Calamak, Semih ^a   Durmus, Naside Gozde ^a   Wang, Shu Qi ^a,c,d   Hanhauser, Emily ^b   Hobbs, Kristen S ^b   Juillard, Franceline ^e   Kuang, Ping Ping ^e   Vetter, Michael L ^e   Carocci, Margot ^e   Yamamoto, Hidemi S ^b   Takagi, Yuko ^e   Yildiz, Umit Hakan ^a   Akin, Demir ^a,f   Wesemann, Duane R ^b,e   Singhal, Amit ^g   Yang, Priscilla L ^e   Nibert, Max L ^e   Fichorova, Raina N ^b   Lau, Daryl T Y ^e   Henrich, Timothy J ^b   Kaye, Kenneth M ^e   Schachter, Steven C ^h   Kuritzkes, Daniel R ^b   Steinmetz, Lars M ^a   Gambhir, Sanjiv S ^a,f,i,j   Davis, Ronald W ^a   Demirci, Utkan ^a,f   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e HARVARD MEDICAL SCHOOL   (United States)

^f STANFORD UNIVERSITY   (United States)

^g AGENCY FOR SCIENCE   (Singapore)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Stanford University   (United States)

^j STANFORD UNIVERSITY   (United States)

more..

Author keywords

Biodetection; Label free; Multiple biotargets; Nanoparticle; Point of need

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; GOLD NANOPARTICLE; NANOMATERIAL;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; ENVIRONMENTAL TEMPERATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNODETECTION; IONIC STRENGTH; KAPOSI SARCOMA; LIMIT OF DETECTION; MIXED INFECTION; NANOFLUIDICS; NANOPLASMONIC ELECTRICAL FIELD ENHANCED RESONATING DEVICE; NONHUMAN; PARTICLE SIZE; PH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; VIRUS LOAD; CHEMISTRY; COINFECTION; DEVICES; DIAGNOSTIC PROCEDURE; ELECTRICITY; ENVIRONMENT; EQUIPMENT DESIGN; GENETIC PROCEDURES; MICROFLUIDICS; OSMOLARITY; REPRODUCIBILITY; TEMPERATURE; TUMOR CELL LINE;

EUKARYOTA;

BIOSENSING TECHNIQUES; CELL LINE, TUMOR; COINFECTION; DIAGNOSTIC TECHNIQUES AND PROCEDURES; ELECTRICITY; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EQUIPMENT DESIGN; HUMANS; HYDROGEN-ION CONCENTRATION; LIMIT OF DETECTION; MICROFLUIDICS; NANOSTRUCTURES; OSMOLAR CONCENTRATION; REPRODUCIBILITY OF RESULTS; TEMPERATURE;

EID: 84938941526     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1510824112     Document Type: Article

References (56)

1. Peeling RW, Smith PG, Bossuyt PMM (2008) A guide for diagnostic evaluations. Nat Rev Microbiol 6(11, Suppl): S2-S6.
2. Banoo S, et al.; TDR Diagnostics Evaluation Expert Panel (2008) Evaluation of diagnostic tests for infectious diseases: General principles. Nat Rev Microbiol 6(11, Suppl): S16-S26.
3. Fichorova RN (2004) Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr 37(Suppl 3): S184-S193.
4. Anker JN, et al. (2008) Biosensing with plasmonic nanosensors. Nat Mater 7(6): 442-453.
5. Cooper MA (2002) Optical biosensors in drug discovery. Nat Rev Drug Discov 1(7): 515-528.
6. Yildiz UH, et al. (2015) Recent advances in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol Adv 33(1): 178-190.
7. Shafiee H, et al. (2015) Emerging technologies for point-of-care management of HIV infection. Annu Rev Med 66: 387-405.
8. Tasoglu S, et al. (2015) Advances in Nanotechnology and Microfluidics for Human Papillomavirus Diagnostics. Proc IEEE 103(2): 161-178.
9. Shafiee H, et al. (2014) Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci Rep 4: 4116.
10. Liu T, et al. (2014) An aggregated perylene-based broad-spectrum, efficient and labelfree quencher for multiplexed fluorescent bioassays. Biosens Bioelectron 58: 320-325.
11. Hu R, et al. (2014) Multicolor fluorescent biosensor for multiplexed detection of DNA. Anal Chem 86(10): 5009-5016.
12. Arlett JL, Myers EB, Roukes ML (2011) Comparative advantages of mechanical biosensors. Nat Nanotechnol 6(4): 203-215.
13. Lissandrello C, et al. (2014) Nanomechanical motion of Escherichia coli adhered to a surface. Appl Phys Lett 105(11): 113701.
14. Das J, et al. (2012) An ultrasensitive universal detector based on neutralizer displacement. Nat Chem 4(8): 642-648.
15. Shafiee H, et al. (2013) Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate. Small 9(15): 2553-2563, 2478.
16. Drummond TG, Hill MG, Barton JK (2003) Electrochemical DNA sensors. Nat Biotechnol 21(10): 1192-1199.
17. Viswanathan S, et al. (2015) Graphene-protein field effect biosensors: Glucose sensing. Mater Today, 10.1016/j.mattod.2015.04.003.
18. Brolo AG (2012) Plasmonics for future biosensors. Nat Photonics 6(11): 709-713.
19. Sönnichsen C, Reinhard BM, Liphardt J, Alivisatos AP (2005) A molecular ruler based on plasmon coupling of single gold and silver nanoparticles. Nat Biotechnol 23(6): 741-745.
20. Tokel O, et al. (2015) Portable microfluidic integrated plasmonic platform for pathogen detection. Sci Rep 5: 9152.
21. Sevimli S, Inci F, Zareie HM, Bulmus V (2012) Well-defined cholesterol polymers with pH-controlled membrane switching activity. Biomacromolecules 13(10): 3064-3075.
22. Inci F, Celik U, Turken B, Özer HÖ, Kok FN (2015) Construction of P-glycoprotein incorporated tethered lipid bilayer membranes. Biochemistry and Biophysics Reports 2: 115-122.
23. Haes AJ, Zou SL, Schatz GC, Van Duyne RP (2004) Nanoscale optical biosensor: Short range distance dependence of the localized surface plasmon resonance of noble metal nanoparticles. J Phys Chem B 108(22): 6961-6968.
24. Beeram SR, Zamborini FP (2009) Selective attachment of antibodies to the edges of gold nanostructures for enhanced localized surface plasmon resonance biosensing. J Am Chem Soc 131(33): 11689-11691.
25. Feuz L, Jönsson P, Jonsson MP, Höök F (2010) Improving the limit of detection of nanoscale sensors by directed binding to high-sensitivity areas. ACS Nano 4(4): 2167-2177.
26. Tokel O, Inci F, Demirci U (2014) Advances in plasmonic technologies for point of care applications. Chem Rev 114(11): 5728-5752.
27. Güngör K, Ünal E, Demir HV (2013) Nanoplasmonic surfaces enabling strong surfacenormal electric field enhancement. Opt Express 21(20): 23097-23106.
28. Liu C, et al. (2012) A 3D localized surface plasmon resonance biosensor for the study of trivalent arsenic binding to the ArsA ATPase. Biosens Bioelectron 38(1): 19-26.
29. Nicoletti O, et al. (2013) Three-dimensional imaging of localized surface plasmon resonances of metal nanoparticles. Nature 502(7469): 80-84.
30. MedlinePlus Medical Encyclopedia (2013) Urine pH test. Available at www.nlm.nih. gov/medlineplus/ency/article/003583.htm Accessed May 8, 2015.
31. Rahman MQ, Chuah KS, Macdonald ECA, Trusler JPM, Ramaesh K (2012) The effect of pH, dilution, and temperature on the viscosity of ocular lubricants-shift in rheological parameters and potential clinical significance. Eye (Lond) 26(12): 1579-1584.
32. Herrmann F, Mandol L (1955) Studies of pH of sweat produced by different forms of stimulation. J Invest Dermatol 24(3): 225-246.
33. Song Y, et al. (2012) Multiplexed volumetric bar-chart chip for point-of-care diagnostics. Nat Commun 3: 1283.
34. Wang S, Inci F, De Libero G, Singhal A, Demirci U (2013) Point-of-care assays for tuberculosis: Role of nanotechnology/microfluidics. Biotechnol Adv 31(4): 438-449.
35. Mani V, et al. (2014) Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care. Adv Drug Deliv Rev 78: 105-117.
36. Zhang B, Kumar RB, Dai H, Feldman BJ (2014) A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nat Med 20(8): 948-953.
37. Antman K, Chang Y (2000) Kaposi's sarcoma. N Engl J Med 342(14): 1027-1038.
38. Caselli E, et al. (2005) Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood 106(8): 2790-2797.
39. Alexaki A, Liu Y, Wigdahl B (2008) Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 6(5): 388-400.
40. Shafiee H, et al. (2015) Paper and flexible substrates as materials for biosensing platforms to detect multiple biotargets. Sci Rep 5: 8719.
41. Inci F, et al. (2013) Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. ACS Nano 7(6): 4733-4745.
42. Yakovleva J, Davidsson R, Bengtsson M, Laurell T, Emnéus J (2003) Microfluidic enzyme immunosensors with immobilised protein A and G using chemiluminescence detection. Biosens Bioelectron 19(1): 21-34.
43. Johnson M (2012) Antibody shelf life/how to store antibodies. Mater Methods 2: 120.
44. Guziewicz N, Best A, Perez-Ramirez B, Kaplan DL (2011) Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies. Biomaterials 32(10): 2642-2650.
45. Zhang J, et al. (2012) Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci USA 109(30): 11981-11986.
46. Song YS, et al. (2010) Vitrification and levitation of a liquid droplet on liquid nitrogen. Proc Natl Acad Sci USA 107(10): 4596-4600.
47. Ramachandran S, Fu E, Lutz B, Yager P (2014) Long-term dry storage of an enzymebased reagent system for ELISA in point-of-care devices. Analyst (Lond) 139(6): 1456-1462.
48. Durmus NG, Tasoglu S, Demirci U (2013) Bioprinting: Functional droplet networks. Nat Mater 12(6): 478-479.
49. Wang S, et al. (2012) Portable microfluidic chip for detection of Escherichia coli in produce and blood. Int J Nanomedicine 7: 2591-2600.
50. Wang S, et al. (2012) Efficient on-chip isolation of HIV subtypes. Lab Chip 12(8): 1508-1515.
51. Gaster RS, et al. (2009) Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat Med 15(11): 1327-1332.
52. Fischer SK, et al. (2015) Emerging technologies to increase ligand binding assay sensitivity. AAPS J 17(1): 93-101.
53. Thaxton CS, et al. (2009) Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci USA 106(44): 18437-18442.
54. Lee H, Sun E, Ham D, Weissleder R (2008) Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 14(8): 869-874.
55. Wang Y, Knoll W, Dostalek J (2012) Bacterial pathogen surface plasmon resonance biosensor advanced by long range surface plasmons and magnetic nanoparticle assays. Anal Chem 84(19): 8345-8350.
56. de la Rica R, Stevens MM (2012) Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat Nanotechnol 7(12): 821-824.